Information gathered in these countries will enable health program planners to make informed decisions regarding whether and how to include Sayana® Press among their family planning offerings.
Family planning could prevent up to one-third of all maternal deaths by allowing women to delay motherhood, space births, avoid unintended pregnancies and unsafe abortions, and stop childbearing when they reach their desired family size.
“This initiative is a major innovation in family planning service delivery,” said PATH President and CEO Steve Davis. “By making injectable contraceptives available at the community level, it offers more women control over the timing and spacing of their children, and a better chance at a healthy life.”
Injectable contraception is a popular family planning method among women in developing countries. In some places, women must return to a clinic every three months for a new injection, limiting access in remote and other hard-to-reach areas. The contraceptive’s delivery system allows injections to be provided by health workers to women at home or in other convenient settings.
The BD Uniject prefilled autodisable injection system was originally developed by PATH, with support from USAID, and has been licensed to Becton, Dickinson and Company (BD). The system allows the contraceptive to be delivered via subcutaneous injection, in the fat layer between the skin and muscle. It also eliminates the need to prepare a needle and syringe.
“At the right price, Sayana® Press will expand contraceptive choice and increase access to family planning, especially in rural and hard-to-reach communities in low-resource settings,” said Ellen Starbird, Director of the Office of Population and Reproductive Health at USAID.
Copyright©2014 Vocus, Inc.
All rights reserved